Skip to main content

Small Crystals, Big Insights: How Electron Diffraction is Transforming Materials, Life Science, and Chemistry Research

#4. Solving Pharma’s Toughest Solid Form Challenges with Electron Diffraction

SCXSeries_summary_E4_1200x300

This is a written summary of a live webinar presented on June 4, 2025. The recording and resources are available on the recording page.

Presented by:

Simon Bates, PhD

VP of Science and Technology

Rigaku Americas

Connect on LinkedIn

Webinar summary

The fourth episode of the webinar series on electron diffraction explores how electron diffraction (ED) can be a transformative tool across the entire pharmaceutical development pipeline, from early discovery to final drug products.

Electron diffraction is an advanced technique used to analyze the structure of materials at the atomic level. Unlike conventional X-ray powder diffraction, ED can work with extremely small amounts of sample—nanograms or less—and provides detailed information grain by grain. This means it can analyze individual tiny crystals within a powder, even in highly impure or early-stage samples.

For pharmaceutical companies, this opens the door to much faster and more precise characterization of drug forms (polymorphs), especially in situations where time and material are limited.

Applications across the development pipeline

Early discovery and preformulation:

Electron diffraction excels at identifying crystalline forms as they appear during early solid formation. Even when only trace crystals are available, ED can identify whether the material is crystalline, determine its unit cell (the fundamental building block of a crystal structure), and even determine the connectivity of the atoms in the molecule.

Unlike other techniques that rely on comparing overall spectral patterns, ED yields unambiguous identification of distinct forms. This minimizes false positives when identifying polymorphs.

Automated high-throughput screening:

ED can be automated to rapidly test thousands of individual grains or liquid-deposited samples, making it well-suited for high-throughput environments. Liquid samples from microplates can be pipetted directly onto grids, evaporated, and analyzed. This is ideal for ligand screening or early-phase crystallization experiments.

Crystal structure prediction integration and early risk assessment:

With modern drug discovery relying on computational crystal structure prediction (CSP), ED bridges the gap by providing real experimental data on the real structures that form, even transiently. These can be used to calibrate CSP models, improving the accuracy of stability predictions and helping ensure the most stable form is chosen early in development.

Downstream utility

Formulation and drug product characterization:

As pharma moves toward nanoparticle delivery systems, ED becomes particularly powerful. It can image and analyze individual lipid nanoparticles, even determining if the active ingredient inside has crystallized. This granularity enables deep insights into how APIs behave inside formulations.

ED also helps study structural disorder, such as changes induced by milling, which can affect performance and manufacturability. It can detect very early phase separation in amorphous solid dispersions and explore atomic-level disorder using advanced techniques like total diffraction and pair distribution function (PDF) analysis.

Finished drug products and IP:

ED is an exceptional tool for reverse-engineering tablets or capsules. With just nanograms of powdered sample, it can identify multiple crystalline forms—e.g., different APIs or excipients—in a drug product. This makes it valuable for detecting counterfeits, validating composition, and checking for potential IP issues.

ED is also sensitive to hydrogen atoms, which means it can distinguish between salts and co-crystals—critical for regulatory classification and patent strategy.

Practical considerations

Electron diffraction requires very small and thin samples (30–300 nanometers thick) and operates under a vacuum. It uses electrons accelerated at very high voltages (e.g., 200 kV), giving it extremely high resolution. Despite concerns about so-called “dynamical diffraction” (where strong interaction between electrons and matter can complicate analysis), modern software tools and automation largely resolve these issues for routine pharmaceutical work.

Automation is a game-changer. Once samples are loaded, the system can align, analyze, and process data from thousands of grains with minimal manual effort. This makes ED viable even in industrial, non-academic settings.

Emerging and routine uses

Routine uses now include:

  • Identifying unknown polymorphs in commercial drug products.
  • Determining absolute structure (molecular “handedness”).
  • Resolving whether a compound is a salt or a cocrystal.
  • Protein crystal structure determination and ligand screening (surprisingly feasible with ED).
  • Characterizing amorphous and disordered systems using total diffraction analysis.

Emerging applications include detailed analysis of lipid nanoparticles and early-stage phase separation in amorphous solid dispersions, with the ultimate goal of understanding and predicting formulation behavior and risks at the nanoscale.

Electron diffraction has evolved into a robust, practical, and indispensable tool for pharmaceutical R&D. Its sensitivity, low sample requirements, and automation make it uniquely suited for today’s challenges—speed, miniaturization, complexity, and the growing importance of polymorph and particle-scale characterization. Whether you're formulating new drugs, investigating unknown substances, or reverse-engineering finished products, ED offers actionable insights no other technique can match.

Key questions answered in this webinar:

Crystallography times editor

Subscribe to the Crystallography Times newsletter

Stay up to date with single crystal analysis news and upcoming events, learn about researchers in the field, new techniques and products, and explore helpful tips.

Contact Us

Whether you're interested in getting a quote, want a demo, need technical support, or simply have a question, we're here to help.